NODE+ / HIGH RISK NODE – / HER2- A011502

Study #A011502

A Randomized Phase III Double-Blinded Placebo-Controlled Trial of Aspirin as Adjuvant Therapy for Node-Positive HER2 Negative Breast Cancer: The ABC Trial.

Back To Clinical Trials